Warrants Finder
Your selection:
898 Results
| GU3T4L | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.557% | 0.740 | -0.013 | 4.174 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW3979 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.822% | 0.715 | -0.008 | 2.548 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW644G | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1.000 | 0.000 | 9.316 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW72V3 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.638% | 0.722 | -0.012 | 3.621 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW730H | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 49.872% | 0.814 | -0.029 | 6.334 | 08/21/2026 | 0.010 | Goldman Sachs | ||
| GW85DW | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.948% | 0.746 | -0.015 | 4.601 | 11/20/2026 | 0.010 | Goldman Sachs | ||
| GW8SYC | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.630% | 0.721 | -0.007 | 2.308 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| GW8SYQ | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.642% | 0.717 | -0.010 | 3.165 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| GW9AJ7 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 720.000 | 22.735% | - | - | - | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GW9AJH | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 750.000 | 17.851% | - | - | - | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GW9AJP | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | 27.394% | - | - | - | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GW9AK6 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 680.000 | 28.524% | - | - | - | 09/18/2026 | 0.100 | Goldman Sachs | ||
| JH5SJC | Regeneron Pharmaceuticals Inc./OS/Call [600]/JPM | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.087% | 0.744 | -0.014 | 4.404 | 12/18/2026 | 0.010 | JP Morgan | ||
| JY1K0Q | Regeneron Pharmaceuticals Inc./OS/Call [600]/JPMD | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.609% | 0.847 | -0.022 | 6.865 | 08/21/2026 | 0.010 | JP Morgan | ||
| MK56VQ |  | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.375% | 0.730 | -0.015 | 4.116 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KFB | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.945% | 0.712 | -0.011 | 3.008 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM5GYR | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.675% | 0.777 | -0.022 | 5.473 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN1W1S | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 650.000 | 24.495% | - | - | - | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN8XD5 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 650.000 | 12.801% | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| MN8XD7 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 650.000 | 16.451% | - | - | - | 11/20/2026 | 0.100 | Morgan Stanley | |
| MN8XD6 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 650.000 | 16.465% | - | - | - | 12/18/2026 | 0.100 | Morgan Stanley | |
| MR03T9 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 49.845% | 0.712 | -0.009 | 2.396 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MR03TA | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.713% | 0.716 | -0.012 | 3.446 | 03/19/2027 | 0.010 | Morgan Stanley | |
| MR3SHH | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 650.000 | 14.842% | - | - | - | 01/15/2027 | 0.100 | Morgan Stanley | |
| MR3SQ3 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | 650.000 | 11.430% | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| SX5KQ8 | Regeneron Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.289% | 0.800 | -0.190 | 5.887 | 09/18/2026 | 0.100 | Société Générale | ||
| FA53HN | Regeneron Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.145% | 0.741 | -0.141 | 4.322 | 12/18/2026 | 0.100 | Société Générale | ||
| VY416A | | Regeneron Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.076% | 0.731 | -0.014 | 4.008 | 01/15/2027 | 0.010 | Vontobel | |
| VY42EA | | Regeneron Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.779% | 0.735 | -0.015 | 4.220 | 12/18/2026 | 0.010 | Vontobel | |
| VY7X53 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.514% | 0.794 | -0.020 | 5.797 | 09/18/2026 | 0.010 | Vontobel | |
| GW9F6S | Regeneron Pharmaceuticals Inc./OS/Call [610]/GOLDS | - | - | 610.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.724% | 0.704 | -0.011 | 3.208 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| GW9FC7 | Regeneron Pharmaceuticals Inc./OS/Call [610]/GOLDS | - | - | 610.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.873% | 0.705 | -0.008 | 2.574 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW9FC5 | Regeneron Pharmaceuticals Inc./OS/Call [610]/GOLDS | - | - | 610.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.434% | 0.711 | -0.008 | 2.338 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| GW9CYW | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.530% | 0.694 | -0.009 | 2.617 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW9D0P | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.561% | 0.689 | -0.012 | 3.840 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW9D11 | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.227% | 0.690 | -0.010 | 3.349 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| GW9D1X | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.730% | 0.702 | -0.008 | 2.316 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| JH5XQJ | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPM | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.393% | 0.702 | -0.014 | 4.717 | 12/18/2026 | 0.010 | JP Morgan | ||
| JE9D3J | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.919% | 0.699 | -0.013 | 4.451 | 01/15/2027 | 0.010 | JP Morgan | ||
| JE9D5P | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.304% | 0.687 | -0.012 | 3.727 | 03/19/2027 | 0.010 | JP Morgan | ||
| JY1K0L | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.134% | 0.778 | -0.027 | 7.800 | 08/21/2026 | 0.010 | JP Morgan | ||
| MK55RG | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.454% | 0.683 | -0.016 | 4.440 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KFC | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.005% | 0.680 | -0.011 | 3.167 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM5GYS | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.178% | 0.710 | -0.024 | 6.178 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MR03TC | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 49.005% | 0.688 | -0.010 | 2.485 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MR03TB | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.618% | 0.677 | -0.013 | 3.677 | 03/19/2027 | 0.010 | Morgan Stanley | |
| MR3CEY | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 54.772% | 0.708 | -0.009 | 2.063 | 06/16/2028 | 0.010 | Morgan Stanley | |
| VY54GS | | Regeneron Pharmaceuticals Inc./OS/Call [625]/VONT | - | - | 625.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.857% | 0.744 | -0.032 | 7.594 | 08/21/2026 | 0.010 | Vontobel | |
| GW9FC3 | Regeneron Pharmaceuticals Inc./OS/Call [630]/GOLDS | - | - | 630.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.470% | 0.694 | -0.008 | 2.379 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| GW9FCE | Regeneron Pharmaceuticals Inc./OS/Call [630]/GOLDS | - | - | 630.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.085% | 0.675 | -0.011 | 3.354 | 06/17/2027 | 0.010 | Goldman Sachs |